ALTACE 1.25 mg MP (Altace 1.25 mg)

Generic Name: ramipril

Pill with imprint ALTACE 1.25 mg MP is Yellow, Capsule-shape and has been identified as Altace 1.25 mg. It is supplied by Monarch Pharmaceuticals, Inc..

Altace is used in the treatment of high blood pressure; diabetic kidney disease; left ventricular dysfunction; cardiovascular risk reduction; heart failure (and more), and belongs to the drug class Angiotensin Converting Enzyme Inhibitors. There is positive evidence of human fetal risk during pregnancy. Altace 1.25 mg is not a controlled substance under the Controlled Substance Act (CSA).

Images for ALTACE 1.25 mg MP

Altace

Generic Name:

ramipril

Imprint:

ALTACE 1.25 mg MP

Strength:

1.25 mg

Color:

Yellow

Size:

4.00 mm

Shape:

Capsule-shape

Availability:

Prescription only

Drug Class:

Angiotensin Converting Enzyme Inhibitors

Pregnancy Category:

D - Positive evidence of risk

CSA Schedule:

Not a controlled drug

Labeler / Supplier:

Monarch Pharmaceuticals, Inc.

Inactive Ingredients:

corn starch
gelatin
titanium dioxide
ferric oxide yellow
Note: Inactive ingredients may vary.

More Info Imprint SearchPrint

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.